Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Cholangiocarcinoma Non-resectable
Wuhan, Hubei
Cholangiocarcinoma Non-resectable Clinical Trials in Wuhan, Hubei
1 recruiting
Wuhan, Hubei, China
Showing
1–1
of
1
trials
Recruiting
Phase 2
Combined HAIC, Lenvatinib and Pucotenlimab As Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma
Cholangiocarcinoma Non-resectable
Tongji Hospital
36 enrolled
1 location
NCT06192797
Feedback